Completed NA INTERVENTIONAL 2-arm NCT04355403

Performance and Safety of Hyalo Gyn Gel on the Treatment of Vaginal Atrophy in Postmenopausal Women

A Prospective, Randomized, Controlled, Open-label Clinical Investigation to Assess the Performance and Safety of Hyalo Gyn Gel Prefilled Applicators on the Treatment of Vaginal Atrophy in Postmenopausal Women

Sponsor: Fidia Farmaceutici s.p.a.

Conditions Vulvovaginal Atrophy

Interventions Hyalo Gyn gel in prefilled applicators

Updated 4 times since 2020 Last updated: Apr 17, 2020 Started: Feb 5, 2019 Primary completion: Jun 28, 2019 Completion: Jun 28, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Vulvovaginal Atrophy and is currently completed. Fidia Farmaceutici s.p.a. leads this study, which shows 4 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
May 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Feb 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fidia Farmaceutici s.p.a.

Data source: Fidia Farmaceutici s.p.a.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bratislava, Slovakia
• Hlohovec, Slovakia